{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CHF", "marketState": "REGULAR", "regularMarketChangePercent": 3.3860068, "regularMarketPrice": 4.58, "exchange": "EBS", "shortName": "NEWRON PHARMA N", "longName": "Newron Pharmaceuticals S.p.A.", "messageBoardId": "finmb_1882829", "exchangeTimezoneName": "Europe/Zurich", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "ch_market", "esgPopulated": false, "regularMarketTime": 1683879543, "earningsTimestamp": 1678791540, "earningsTimestampStart": 1678791540, "earningsTimestampEnd": 1678791540, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.94, "epsForward": -0.54, "epsCurrentYear": -0.58, "priceEpsCurrentYear": -7.8965516, "sharesOutstanding": 17845300, "bookValue": -0.786, "fiftyDayAverage": 5.3546, "fiftyDayAverageChange": -0.7746, "fiftyDayAverageChangePercent": -0.14466067, "twoHundredDayAverage": 2.84205, "twoHundredDayAverageChange": 1.7379498, "twoHundredDayAverageChangePercent": 0.6115127, "marketCap": 84130016, "forwardPE": -8.481481, "priceToBook": -5.826972, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.5 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1165910400000, "priceHint": 4, "regularMarketChange": 0.1500001, "regularMarketDayHigh": 4.58, "regularMarketDayRange": "4.5 - 4.58", "regularMarketDayLow": 4.5, "regularMarketVolume": 504, "regularMarketPreviousClose": 4.43, "bid": 4.43, "ask": 4.58, "bidSize": 0, "askSize": 0, "fullExchangeName": "Swiss", "financialCurrency": "EUR", "regularMarketOpen": 4.5, "averageDailyVolume3Month": 160492, "averageDailyVolume10Day": 29468, "fiftyTwoWeekLowChange": 3.57, "fiftyTwoWeekLowChangePercent": 3.5346534, "fiftyTwoWeekRange": "1.01 - 9.18", "fiftyTwoWeekHighChange": -4.6000004, "fiftyTwoWeekHighChangePercent": -0.50108933, "fiftyTwoWeekLow": 1.01, "fiftyTwoWeekHigh": 9.18, "symbol": "NWRN.SW"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Via Antonio Meucci 3", "city": "Bresso", "state": "MI", "zip": "20091", "country": "Italy", "phone": "39 02 610 3461", "fax": "39 02 610 34654", "website": "https://www.newron.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea. The company's product pipeline includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. In addition, it has a strategic partnership with Zambon for the commercialization of safinamide; and license agreement with Meiji Seika Pharma Co., Ltd., for research, develop, manufacture, and marketing of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stefan  Weber", "age": 57, "title": "CEO & Exec. Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 471127, "fmt": "471.13k", "longFmt": "471,127"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Roberto  Galli", "title": "VP of Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Filippo  Moriggia", "title": "VP of Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marco  Caremi", "age": 65, "title": "Exec. VP of Bus. Devel.", "yearBorn": 1957, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ravi  Anand", "age": 65, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 1109182, "fmt": "1.11M", "longFmt": "1,109,182"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}